Bonney Michael W

Director at ALNY; Chief Executive Officer at CUBIST PHARMACEUTICALS INC; Director at NPS PHARMACEUTICALS INC

Sold, on record
$42.3M
Dollars the filings state
Form 4 sales
18
Latest Aug 18, 2025
Form 144 notices
3
Proposed sales
Companies
3
Filed as an executive or holder

Companies

Sales by reason

3
Routine
8
Plan not stated
0
No plan
7
Unusual
Stacked: routine sales under a plan, sales whose filing does not state a plan, sales with no plan, and unusual sales.

Form 4 sales per year, every sale on record.

Sales chart range

Sales by company

Shares sold, every Form 4 sale on record.

Timeline

  1. Aug 18, 2025Routine

    ALNY

    Sold 40.1% of their holdings

    $5.1M11,250 shares at $450.00

    Filed Aug 19, 2025Form 4

  2. Aug 18, 2025Notice

    ALNY

    Filed a notice to sell 11,250 shares

    $5.1M11,250 shares

    Filed Aug 18, 2025Form 144

  3. May 15, 2025Routine

    ALNY

    Sold 40.1% of their holdings

    $3.1M11,250 shares at $277.71

    Filed May 19, 2025Form 4

  4. May 15, 2025Notice

    ALNY

    Filed a notice to sell 11,250 shares

    $3M11,250 shares

    Filed May 15, 2025Form 144

  5. Dec 27, 2023Routine

    ALNY

    Sold 65.2% of their holdings

    $5.8M30,000 shares at $195.00

    Filed Dec 29, 2023Form 4

  6. Dec 27, 2023Notice

    ALNY

    Filed a notice to sell 30,000 shares

    $5.7M30,000 shares

    Filed Dec 27, 2023Form 144

  7. Aug 3, 2023Unusual

    ALNY

    Sold 28.7% of their holdings

    $1.2M6,448 shares at $185.38

    Filed Aug 4, 2023Form 4

  8. May 15, 2014Plan not stated

    CUBIST PHARMACEUTICALS INC

    Sold 1.7% of their holdings

    $205k3,036 shares at $67.50

    Filed May 15, 2014Form 4

  9. May 14, 2014Plan not stated

    CUBIST PHARMACEUTICALS INC

    Sold 2.2% of their holdings

    $265k3,840 shares at $69.00

    Filed May 14, 2014Form 4

  10. Feb 27, 2014Unusual

    CUBIST PHARMACEUTICALS INC

    Sold 37.2% of their holdings

    $8.1M100,000 shares at $81.25

    Filed Feb 28, 2014Form 4

10 of 21

Every transaction

Every transaction on a Form 4 or Form 5 by Bonney Michael W
TradedFiledStockRoleWhatAmountPriceValueHeld afterSource
Jun 29, 2026Jul 1, 2026AUTLDirectorAwardedRestricted Share Units79,16747,500SEC
Jun 29, 2026Jun 29, 2026IMUXDirectorAwardedStock Option100,000100,000SEC
Aug 18, 2025Aug 19, 2025ALNYDirectorSold11,250$450.00$5.1M16,804SEC
Aug 18, 2025Aug 19, 2025ALNYDirectorExercised or settledStock Option (right to buy)11,2500SEC
Aug 18, 2025Aug 19, 2025ALNYDirectorExercised options11,250$70.20$790k28,054SEC
May 15, 2025May 19, 2025ALNYDirectorSold11,250$277.71$3.1M16,804SEC
May 15, 2025May 19, 2025ALNYDirectorExercised or settledStock Option (right to buy)11,2500SEC
May 15, 2025May 19, 2025ALNYDirectorExercised options11,250$131.21$1.5M28,054SEC
May 8, 2025May 12, 2025ALNYDirectorAwardedStock Option (right to buy)1,5581,558SEC
May 8, 2025May 12, 2025ALNYDirectorAwarded77516,804SEC
May 16, 2024May 20, 2024ALNYDirectorAwardedStock Option (right to buy)5,2285,228SEC
Dec 27, 2023Dec 29, 2023ALNYDirectorSold30,000$195.00$5.8M16,029SEC
Dec 27, 2023Dec 29, 2023ALNYDirectorExercised or settledStock Option (right to buy)30,0000SEC
Dec 27, 2023Dec 29, 2023ALNYDirectorExercised options30,000$96.45$2.9M46,029SEC
Aug 3, 2023Aug 4, 2023ALNYDirectorSold6,448$185.38$1.2M16,029SEC
Aug 2, 2023Aug 4, 2023ALNYDirectorExercised or settledRestricted Stock Units22,4770SEC
Aug 2, 2023Aug 4, 2023ALNYDirectorExercised options22,47722,477SEC
May 18, 2023May 19, 2023ALNYDirectorAwardedStock Option (right to buy)3,4543,454SEC
Aug 2, 2021Aug 3, 2021ALNYExecutive ChairAwardedRestricted Stock Units22,47722,477SEC
Jul 15, 2021Jul 19, 2021ALNYDirectorAwardedStock Option (right to buy)4,0324,032SEC
Jun 30, 2021Jul 1, 2021Kaleido Biosciences, Inc.DirectorAwardedStock Option (Right to Buy)30,00015,000SEC
Jun 30, 2021Jul 1, 2021BMYDirectorAwardedDeferred Share Units3459,342SEC
Jun 13, 2021Jun 14, 2021BMYDirectorExercised or settledRestricted Stock Units9020SEC
Jun 13, 2021Jun 14, 2021BMYDirectorExercised options90212,501SEC
Jun 3, 2021Jun 4, 2021BMYDirectorExercised or settledRestricted Stock Units2,9492,949SEC
Jun 3, 2021Jun 4, 2021BMYDirectorExercised options2,94911,599SEC
Jun 1, 2021Jun 3, 2021DNTHDirectorAwardedStock Option (Right to Buy)18,18818,188SEC
Mar 31, 2021Apr 2, 2021BMYDirectorAwardedDeferred Share Units366$63.13$23k8,930SEC
Feb 1, 2021Feb 3, 2021BMYDirectorAwardedDeferred Share Units3,054$62.21$190k8,565SEC
Dec 31, 2020Jan 5, 2021BMYDirectorAwardedDeferred Share Units372$62.03$23k5,468SEC
Sep 30, 2020Oct 2, 2020BMYDirectorAwardedDeferred Share Units383$60.29$23k5,057SEC
Jul 1, 2020Jul 6, 2020ALNYDirectorAwardedStock Option (right to buy)4,5814,581SEC
Jun 30, 2020Jul 1, 2020Kaleido Biosciences, Inc.DirectorAwardedStock Option (Right to Buy)15,00015,000SEC
Jun 30, 2020Jul 2, 2020BMYDirectorAwardedDeferred Share Units392$58.80$23k4,639SEC
Jun 14, 2020Jun 16, 2020BMYDirectorExercised or settledRestricted Stock Units1,4610SEC
Jun 14, 2020Jun 16, 2020BMYDirectorExercised options1,4618,650SEC
Jun 5, 2020Jun 9, 2020DNTHDirectorAwardedStock Option (Right to Buy)18,18818,188SEC
Jun 3, 2020Jun 5, 2020BMYDirectorExercised or settledRestricted Stock Units2,9495,898SEC
Jun 3, 2020Jun 5, 2020BMYDirectorExercised options2,9497,189SEC
Mar 31, 2020Apr 2, 2020BMYDirectorAwardedDeferred Share Units414$55.74$23k4,215SEC
Feb 28, 2020Feb 28, 2020SRPTDirectorAwardedStock option (right to buy)3,6853,685SEC
Feb 28, 2020Feb 28, 2020SRPTDirectorAwarded2,0759,126SEC
Feb 1, 2020Feb 4, 2020BMYDirectorAwardedDeferred Share Units3,018$62.95$190k3,801SEC
Dec 31, 2019Jan 3, 2020BMYDirectorAwardedDeferred Share Units126$64.19$8k782SEC
Dec 4, 2019Jun 9, 2020BMYDirectorBought88$58.90$5k7,189SEC
Nov 20, 2019Nov 22, 2019CELGENE CORP /DE/DirectorReturned to the companyStock Option (right to buy)61,7920SEC
Nov 20, 2019Nov 22, 2019CELGENE CORP /DE/DirectorReturned to the company4,2090SEC
Nov 20, 2019Nov 22, 2019BMYDirectorAwardedDeferred Share Units656$56.41$37k656SEC
Sep 9, 2019Sep 9, 2019SRPTDirectorBought2,000$86.74$173k7,051SEC
Jul 1, 2019Jul 2, 2019ALNYDirectorAwardedStock Option (right to buy)9,0009,000SEC
Page 1

Sales and notices (21)

Form 144 notices and Form 4 sales by Bonney Michael W
Source
Aug 18, 2025Aug 19, 2025ALNYDirectorForm 4 sale11,250$5.1M40.1%RoutineSEC
Aug 18, 2025Aug 18, 2025ALNYDirectorForm 144 notice11,250$5.1MNoticeSEC
May 15, 2025May 19, 2025ALNYDirectorForm 4 sale11,250$3.1M40.1%RoutineSEC
May 15, 2025May 15, 2025ALNYDirectorForm 144 notice11,250$3MNoticeSEC
Dec 27, 2023Dec 29, 2023ALNYDirectorForm 4 sale30,000$5.8M65.2%RoutineSEC
Dec 27, 2023Dec 27, 2023ALNYDirectorForm 144 notice30,000$5.7MNoticeSEC
Aug 3, 2023Aug 4, 2023ALNYDirectorForm 4 sale6,448$1.2M28.7%UnusualSEC
May 15, 2014May 15, 2014CUBIST PHARMACEUTICALS INCChief Executive OfficerForm 4 sale3,036$205k1.7%Plan not statedSEC
May 14, 2014May 14, 2014CUBIST PHARMACEUTICALS INCChief Executive OfficerForm 4 sale3,840$265k2.2%Plan not statedSEC
Feb 27, 2014Feb 28, 2014CUBIST PHARMACEUTICALS INCChief Executive OfficerForm 4 sale100,000$8.1M37.2%UnusualSEC
Feb 20, 2014Feb 21, 2014CUBIST PHARMACEUTICALS INCChief Executive OfficerForm 4 sale3,112$235k1.8%Plan not statedSEC
May 20, 2013May 22, 2013CUBIST PHARMACEUTICALS INCChief Executive OfficerForm 4 sale60,000$3M27.1%UnusualSEC
May 16, 2013May 17, 2013CUBIST PHARMACEUTICALS INCChief Executive OfficerForm 4 sale2,400$115k1.5%Plan not statedSEC
May 15, 2013May 16, 2013CUBIST PHARMACEUTICALS INCChief Executive OfficerForm 4 sale2,979$144k1.8%Plan not statedSEC
May 14, 2013May 15, 2013CUBIST PHARMACEUTICALS INCChief Executive OfficerForm 4 sale3,753$185k2.4%Plan not statedSEC
Feb 7, 2013Feb 11, 2013NPS PHARMACEUTICALS INCDirectorForm 4 sale5,325$47k27.7%UnusualSEC
Jan 29, 2013Jan 30, 2013CUBIST PHARMACEUTICALS INCPresident & CEOForm 4 sale105,452$4.5M42.5%UnusualSEC
May 16, 2012May 16, 2012CUBIST PHARMACEUTICALS INCPresident and CEOForm 4 sale4,245$178k2.8%Plan not statedSEC
May 14, 2012May 15, 2012CUBIST PHARMACEUTICALS INCPresident and CEOForm 4 sale2,927$122k2.0%Plan not statedSEC
Dec 20, 2011Dec 21, 2011CUBIST PHARMACEUTICALS INCPresident and CEOForm 4 sale150,000$5.8M52.6%UnusualSEC
Apr 22, 2010Apr 23, 2010CUBIST PHARMACEUTICALS INCPresident and CEOForm 4 sale184,548$4.2M75.4%UnusualSEC